Test Price
2,800 AED✅ Home Collection Available
ADNP Gene Genetic Test for Mental Retardation (Autosomal Dominant Type 28) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ADNP للكشف عن التخلف العقلي الجسدي السائد من النوع 28 (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي | Executive Summary
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة وفق معيار ISO. (Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing)
- خدمة لوجستية متميزة: سحب عينات منزلية على مستوى المستشفيات عبر خدمة "النقل المبرد المعتمد من ISO" و"خدمة VIP لفصد الدم المتنقل". (Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain & VIP Mobile Phlebotomy)
- التوجيه السريري: استشارة هاتفية بعد الاختبار لتفسير النتائج مع خبير. (Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation)
- التأمين: التحقق المباشر من تغطية التأمين عبر واتساب على الرقم +971 54 548 8731. (Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731)
Overview / نظرة عامة
This advanced next-generation sequencing (NGS) test analyzes the entire coding region of the ADNP gene to detect pathogenic variants causing autosomal dominant mental retardation type 28 (Helsmoortel-van der Aa syndrome). يُحلل الفحص الجيني المتطور بتقنية الجيل التالي الجين ADNP لتشخيص التخلف العقلي الجسدي السائد من النوع 28 (متلازمة هيلزمورتل-فان دير آ).
| Feature | Our Test (NGS ADNP) | Closest Alternative (Whole Exome) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity for ADNP variants, deep intronic coverage | ~95% for coding variants, limited intronic analysis |
| Methodology | Targeted NGS with full exon and intron-border sequencing | Whole exome sequencing (WES) – broader but shallower |
| Turnaround Time | 3–4 Weeks (focused analysis) | 6–10 Weeks (complex data interpretation) |
Physician Insight & Safety Protocol
“As a clinical neurologist, I emphasize that a genetic result must always be correlated with the patient’s developmental history and family pedigree. This test provides clarity for families seeking answers about intellectual disability, but it does not replace comprehensive neurodevelopmental assessment.” — Dr. PRABHAKAR REDDY, DHA License 61713011
“An ADNP mutation can present with a wide spectrum—from mild learning difficulties to severe autism and seizures. Our role is to guide you through the clinical meaning of every variant, ensuring no alarming result is left unexplained.”
“I strongly advise discussing all results with a medical geneticist or pediatric neurologist before initiating any therapy or lifestyle changes.”
⚠ Medication Warning
Do not discontinue or alter any prescribed medication or therapy based solely on this genetic test result without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or unstable clinical condition – postpone blood draw
- Inability to provide adequate venous access (consult alternative sample collection)
- For minors: mandatory pre‑test genetic counselling as per UAE CDS Law 2026
- Seek immediate medical attention if: sudden loss of developmental skills, new‑onset seizures, or severe behavioural regression after receiving results
Patient FAQ & Clinical Guidance
1. What is the ADNP gene test and who should consider it?
This NGS test identifies pathogenic variants in the ADNP gene, providing a definitive molecular diagnosis for autosomal dominant intellectual disability with high clinical sensitivity.
It is recommended for children and adults with unexplained developmental delay, autism spectrum features, distinctive facial dysmorphisms, or a family history suggestive of ADNP-related disorder. Neurologists, clinical geneticists, and pediatricians commonly order this test after a thorough clinical evaluation and genetic counselling, mandatory under UAE regulations (Federal Decree‑Law No. 41 of 2024, Art. 87).
يوصى بهذا الفحص للأطفال والبالغين الذين يعانون من تأخر في النمو غير المفسر، سمات طيف التوحد، أو تشوهات وجهية مميزة، ويجب إجراؤه بعد استشارة وراثية إلزامية وفق القانون الاتحادي رقم 41 لسنة 2024.
2. How accurate is the and what does a negative result mean?
Our targeted NGS achieves >99.9% analytical sensitivity and specificity for single nucleotide variants and small indels within the ADNP coding region, nearly eliminating false negatives.
A negative report significantly reduces the likelihood of ADNP-related disorder, but does not exclude rare deep intronic alterations or large deletions not covered by current probes. In such cases, additional genetic testing (e.g., chromosomal microarray) may be warranted. All findings are interpreted according to ACMG 2026 guidelines and correlated with clinical phenotype.
النتيجة السلبية تقلل بشكل كبير من احتمالية الإصابة بمتلازمة ADNP، لكنها لا تستبعد وجود طفرات نادرة عميقة داخل الإنترونات، وقد يتطلب التشخيص فحوصات جينية إضافية.
3. How is the home collection arranged and is my data protected under UAE law?
A certified phlebotomist visits your home between 8 AM and 11 PM with full cold‑chain logistics, ensuring sample integrity while maintaining complete privacy and data security.
Schedule collection via WhatsApp at +971 54 548 8731. All procedures comply with the UAE Personal Data Protection Law (PDPL). Your genetic information is stored in an encrypted, ISO 9001:2015‑certified database, and never shared without explicit consent, except as mandated by law for public health reporting.
يتم ترتيب سحب العينة منزليًا عبر واتساب، مع الالتزام الكامل بقانون حماية البيانات الشخصية الإماراتي، وتخزين المعلومات الجينية بشكل مشفر ومعتمد بمعيار ISO 9001:2015.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians